[go: up one dir, main page]

MX9203396A - Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas. - Google Patents

Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas.

Info

Publication number
MX9203396A
MX9203396A MX9203396A MX9203396A MX9203396A MX 9203396 A MX9203396 A MX 9203396A MX 9203396 A MX9203396 A MX 9203396A MX 9203396 A MX9203396 A MX 9203396A MX 9203396 A MX9203396 A MX 9203396A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
produce
mometasone furoate
furoate monohydrate
monohydrate
Prior art date
Application number
MX9203396A
Other languages
English (en)
Inventor
Pui-Ho Yuen
Charles Eckhart
Teresa Etlinger
Nancy Levine
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24320279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9203396(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX9203396A publication Critical patent/MX9203396A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX9203396A 1990-09-10 1991-09-06 Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas. MX9203396A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58023990A 1990-09-10 1990-09-10
PCT/US1991/006249 WO1992004365A1 (en) 1990-09-10 1991-09-06 Mometasone furoate monohydrate, process for making same and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MX9203396A true MX9203396A (es) 1992-07-31

Family

ID=24320279

Family Applications (2)

Application Number Title Priority Date Filing Date
MX9203396A MX9203396A (es) 1990-09-10 1991-09-06 Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas.
MX9100990A MX9100990A (es) 1990-09-10 1991-09-09 Compuesto monohidrato de furoato de mometasona,al procedimiento para su preparacion y a las composiciones farmaceuticas

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX9100990A MX9100990A (es) 1990-09-10 1991-09-09 Compuesto monohidrato de furoato de mometasona,al procedimiento para su preparacion y a las composiciones farmaceuticas

Country Status (35)

Country Link
US (1) US6180781B1 (es)
EP (1) EP0548114B1 (es)
JP (1) JPH0725789B2 (es)
KR (1) KR960013445B1 (es)
CN (1) CN1030920C (es)
AT (1) ATE113604T1 (es)
AU (1) AU663471B2 (es)
BG (1) BG60755B2 (es)
CA (1) CA2091360C (es)
CZ (1) CZ281318B6 (es)
DE (2) DE69104991T2 (es)
DK (1) DK0548114T5 (es)
EE (1) EE02962B1 (es)
ES (1) ES2065701T3 (es)
FI (1) FI111078B (es)
HK (1) HK185996A (es)
HR (1) HRP920383B1 (es)
HU (1) HU213401B (es)
IE (1) IE67056B1 (es)
IL (1) IL99437A (es)
LU (1) LU90366I2 (es)
MX (2) MX9203396A (es)
MY (1) MY106644A (es)
NL (1) NL980012I2 (es)
NO (1) NO300548B1 (es)
NZ (1) NZ239711A (es)
OA (1) OA09772A (es)
PH (1) PH30443A (es)
PL (1) PL165803B1 (es)
PT (1) PT98905B (es)
SI (1) SI9111497A (es)
TW (2) TW272195B (es)
WO (1) WO1992004365A1 (es)
YU (1) YU48666B (es)
ZA (1) ZA917148B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69104991T2 (de) * 1990-09-10 1995-04-20 Schering Corp Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US5837699A (en) * 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
CN1059476C (zh) * 1996-08-21 2000-12-13 邓维鹏 金黄色铝合金硒盐电解着色方法
EP1033991B1 (en) * 1997-10-09 2002-04-17 Schering Corporation Mometasone furoate suspensions for nebulization
US6187765B1 (en) * 1997-10-09 2001-02-13 Schering Corporation Mometasone furoate suspensions for nebulization
MY133181A (en) * 1998-09-10 2007-10-31 Schering Corp Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
BR0010708A (pt) 1999-05-04 2002-02-19 Strakan Ltd Glicosìdeos androgênicos e atividade androgênica dos mesmos
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
US7811606B2 (en) 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en) 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7825147B2 (en) * 2003-08-29 2010-11-02 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-IV
WO2005051931A2 (en) * 2003-11-26 2005-06-09 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
WO2007045980A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
EP1948164A1 (en) 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Pharmaceutical compositions of muscarinic receptor antagonists
CN100389121C (zh) * 2005-12-09 2008-05-21 天津药业集团有限公司 糠酸莫美他松中间体21-羟的制备方法
CN100436473C (zh) * 2005-12-09 2008-11-26 天津药业集团有限公司 糠酸莫美他松中间体21-酯及制法
DE102006034883A1 (de) * 2006-07-25 2008-01-31 Hermal Kurt Herrmann Gmbh & Co. Ohg Pharmazeutische Zusammensetzung enthaltend Mometasonfuroat
AU2007298549A1 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-IV
EP2066661A2 (en) * 2006-09-22 2009-06-10 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
WO2008111009A1 (en) * 2007-03-14 2008-09-18 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
HRP20120361T1 (hr) * 2007-03-14 2012-05-31 Ranbaxy Laboratories Limited DERIVATI PIRAZOLO[3,4-b]PIRIDINA KAO INHIBITORI FOSFODIESTERAZE
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
PL3111926T3 (pl) 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje, sposoby i układy do dostarczania dwóch lub większej liczby środków czynnych do układu oddechowego
US8815258B2 (en) * 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PT105058B (pt) 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
CA2905542C (en) 2013-03-15 2022-05-03 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法
CN107260671B (zh) * 2016-04-08 2021-03-26 天津金耀集团有限公司 一种糠酸莫米松混悬鼻喷剂组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
US4783444A (en) 1984-09-17 1988-11-08 Schering Corporation Antiglaucoma compositions and methods
US4808610A (en) * 1986-10-02 1989-02-28 Schering Corporation Mometasone furoate anti-inflammatory cream composition using hexylene glycol
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
DE69104991T2 (de) * 1990-09-10 1995-04-20 Schering Corp Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.

Also Published As

Publication number Publication date
CZ38393A3 (en) 1994-01-19
DE69104991T2 (de) 1995-04-20
NO300548B1 (no) 1997-06-16
OA09772A (en) 1993-11-30
HK185996A (en) 1996-10-11
IE913155A1 (en) 1992-03-11
MX9100990A (es) 1992-05-04
EP0548114B1 (en) 1994-11-02
US6180781B1 (en) 2001-01-30
CZ281318B6 (cs) 1996-08-14
NL980012I2 (nl) 2004-11-01
MY106644A (en) 1995-07-31
PT98905B (pt) 1998-08-31
TW272195B (es) 1996-03-11
CA2091360C (en) 1997-04-08
DE69104991D1 (de) 1994-12-08
BG60755B2 (bg) 1996-02-29
HUT64361A (en) 1993-12-28
FI931031A0 (fi) 1993-03-09
CN1030920C (zh) 1996-02-07
IE67056B1 (en) 1996-02-21
IL99437A (en) 1995-05-29
KR960013445B1 (ko) 1996-10-05
NO930693L (no) 1993-02-26
ES2065701T3 (es) 1995-02-16
HU213401B (en) 1997-06-30
WO1992004365A1 (en) 1992-03-19
TW229208B (es) 1994-09-01
LU90366I2 (fr) 1999-05-05
YU48666B (sh) 1999-06-15
JPH0725789B2 (ja) 1995-03-22
DE19875032I2 (de) 2007-04-19
SI9111497A (sl) 1998-04-30
CN1059911A (zh) 1992-04-01
PH30443A (en) 1997-05-09
NZ239711A (en) 1992-09-25
HU9300685D0 (en) 1993-06-28
AU663471B2 (en) 1995-10-12
DK0548114T5 (da) 1995-01-30
EE02962B1 (et) 1997-02-17
AU8497491A (en) 1992-03-30
JPH05506667A (ja) 1993-09-30
NL980012I1 (nl) 1998-05-06
HRP920383B1 (en) 2000-04-30
CA2091360A1 (en) 1992-03-11
IL99437A0 (en) 1992-08-18
PT98905A (pt) 1992-09-30
NO930693D0 (no) 1993-02-26
EP0548114A1 (en) 1993-06-30
YU149791A (sh) 1994-01-20
ATE113604T1 (de) 1994-11-15
FI931031L (fi) 1993-03-09
ZA917148B (en) 1992-08-26
HRP920383A2 (en) 1998-06-30
FI111078B (fi) 2003-05-30
PL165803B1 (pl) 1995-02-28

Similar Documents

Publication Publication Date Title
MX9203396A (es) Monohidrato de furoato de mometasona, proceso para producirlo y composiciones farmaceuticas.
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
MA22842A1 (fr) Procede de preparation de compositions de vaccin.
GB2210879B (en) 4h-1-benzopyran-4-one derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
SE8700499D0 (sv) Novel pharmacologically active compounds
NL950007I1 (nl) 1,2,4-Triazinederivaten, werkwijze voor de bereid ing van deze verbindingen, en deze verbindingen bevattende farmaceutische preparaten.
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
RU93004445A (ru) Новые 2-циано 3-гидроксиенамидные производные, способ их получения, их применение в качестве медикаментов, содержащие их фармацевтические композиции и новые полученные промежуточные продукты
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
IL101358A0 (en) Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
IT7927243A0 (it) Per la loro preparazione e composti triazinonici, procedimenti composizioni farmaceutiche che licontengono.
DK0577745T3 (da) Bis-naphtalimider indeholdende amid- og thioamid-forbindelsesstykker som anticancermidler.
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
ES474052A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas.
FI945414A0 (fi) Menetelmä N,N-disubstituoidun aminofenolin valmistamiseksi
ES444600A1 (es) Un procedimiento de obtencion de los 3-azadiespirodecanos.
RU94019328A (ru) α- ГЕТЕРОАРИЛОКСИМЕТИЛКЕТОНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ИНГИБИРУЮЩАЯ ИНТЕРЛЕЙКИН-1 - β -ПРОТЕАЗУ
IT1255696B (it) Composto con attivita' vasodilatatrice procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono